ES2033747T3 - Preparacion de polipeptidos relacionados con factores de ligacion. - Google Patents

Preparacion de polipeptidos relacionados con factores de ligacion.

Info

Publication number
ES2033747T3
ES2033747T3 ES198787110458T ES87110458T ES2033747T3 ES 2033747 T3 ES2033747 T3 ES 2033747T3 ES 198787110458 T ES198787110458 T ES 198787110458T ES 87110458 T ES87110458 T ES 87110458T ES 2033747 T3 ES2033747 T3 ES 2033747T3
Authority
ES
Spain
Prior art keywords
guests
preparation
polypeptides related
polypeptides
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787110458T
Other languages
English (en)
Inventor
Hans Dr. Hofstetter
Erich Dr. Kilchherr
Albert Dr. Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868617862A external-priority patent/GB8617862D0/en
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2033747T3 publication Critical patent/ES2033747T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A POLIPEPTIDOS RELACIONADOS CON LOS FACTORES DE FIJACION DE LA INMUNOGLOBULINA E HUMANA (IGE-BFS), MRNAS, ADNS Y VECTORES HIBRIDOS QUE CODIFICAN DICHOS POLIPEPTIDOS, HUESPED QUE CONTIENE DICHOS VECTORES HIBRIDOS, PROCEDIMIENTO PARA LA PREPARACION DE DICHOS POLIPEPTIDOS, MRNAS, ADNS, VECTORES HIBRIDOS Y HUESPEDES. LOS POLIPEPTIDOS PUEDEN UTILIZARSE PARA PREVENIR Y/O TRATAR ENFERMEDADES ALERGICAS Y, POR CONSIGUIENTE, LA INVENCION CONCIERNE TAMBIEN A PREPARACIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES198787110458T 1986-07-22 1987-07-20 Preparacion de polipeptidos relacionados con factores de ligacion. Expired - Lifetime ES2033747T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868617862A GB8617862D0 (en) 1986-07-22 1986-07-22 Binding factor related polypeptides
GB868626622A GB8626622D0 (en) 1986-07-22 1986-11-07 Polypeptides

Publications (1)

Publication Number Publication Date
ES2033747T3 true ES2033747T3 (es) 1993-04-01

Family

ID=26291074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787110458T Expired - Lifetime ES2033747T3 (es) 1986-07-22 1987-07-20 Preparacion de polipeptidos relacionados con factores de ligacion.

Country Status (10)

Country Link
US (1) US5081028A (es)
EP (1) EP0254249B1 (es)
JP (2) JP2713912B2 (es)
AU (1) AU602907B2 (es)
DE (1) DE3781217T2 (es)
DK (1) DK172259B1 (es)
ES (1) ES2033747T3 (es)
GR (1) GR3006306T3 (es)
IE (1) IE60393B1 (es)
PT (1) PT85364B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272255A (en) * 1985-01-26 1993-12-21 Ciba-Geigy Corporation Polypeptide factors from colostrum
GB8514732D0 (en) * 1985-06-11 1985-07-10 Ciba Geigy Ag Purified immunoglobulin-related factor
EP0248211B1 (en) * 1986-04-30 1992-03-11 Junji Yodoi Novel protein and a method for production thereof
EP0259585B1 (en) * 1986-07-29 1993-06-09 Kishimoto, Tadamitsu, Prof. Monoclonal antibodies specific to surface receptor for ige and hybrid cell lines producing these antibodies and use thereof
AU628034B2 (en) * 1987-11-19 1992-09-10 3I Research Exploitation Limited Immunoglobulin e competitor
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
EP1007673B1 (en) * 1997-07-30 2008-12-17 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
DE19746874A1 (de) * 1997-10-23 1999-04-29 Qiagen Gmbh Verfahren zur Isolierung und Reinigung von Nukleinsäuren an hydrophoben Oberflächen - insbesondere unter Verwendung hydrophober Membranen
US6410714B1 (en) * 1999-03-24 2002-06-25 Heska Corporation Canine low affinity IgE receptor (CD23) nucleic acid molecules and uses thereof
DE10147439B4 (de) * 2001-09-26 2014-01-30 Qiagen Gmbh Verfahren zur Isolierung von DNA aus biologischen Proben
WO2004078965A1 (ja) * 2003-03-05 2004-09-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 大腸菌における異種蛋白質の製造方法
JP2009131151A (ja) * 2006-02-28 2009-06-18 Osaka Univ ＰＩＬＲαと結合するポリペプチド、およびそれをコードするポリヌクレオチド、並びにその利用
US8945575B2 (en) * 2009-12-01 2015-02-03 Trustees Of Boston University Treatment of IgE-mediated disease
JP6911577B2 (ja) * 2017-06-28 2021-07-28 住友ゴム工業株式会社 二輪自動車用タイヤ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU542264B2 (en) * 1979-06-01 1985-02-14 G.D. Searle & Co. Plasmid vectors
US4666847A (en) * 1981-01-16 1987-05-19 Collaborative Research, Inc. Recombinant DNA means and method
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4758511A (en) * 1984-03-16 1988-07-19 Dnax Research Institute Of Molecular And Cellular Biology, Inc. CDNA clones coding for polypeptides exhibiting IGE binding factor activity
JPS61268184A (ja) * 1984-11-05 1986-11-27 Green Cross Corp:The 組換えプラスミド及び当該プラスミドによる形質転換株
JPS62502939A (ja) * 1985-04-23 1987-11-26 メディカル・バイオロジ−・インスティチュ−ト 分子クロ−ニングによるＩｇＥ結合蛋白質の同定
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0248211B1 (en) * 1986-04-30 1992-03-11 Junji Yodoi Novel protein and a method for production thereof
JPH085917B2 (ja) * 1986-04-30 1996-01-24 淳司 淀井 新規な蛋白質およびその製法
EP0257114A1 (en) * 1986-08-21 1988-03-02 Kishimoto, Tadamitsu, Prof. Human low affinity Fc epsilon-receptor, the isolation and purification thereof
EP0259615A1 (en) * 1986-08-21 1988-03-16 Kishimoto, Tadamitsu, Prof. Human low affinity Fc epsilon-receptor, the isolation, the recombinant preparation and purification thereof
AU8270187A (en) * 1986-10-28 1988-05-25 Memorial Sloan-Kettering Cancer Center Dna expressing fc receptor protein
JPH07107079A (ja) * 1993-10-07 1995-04-21 Hitachi Ltd 周波数位相同期回路および情報転送周波数変換回路ならびに通信端末装置

Also Published As

Publication number Publication date
EP0254249B1 (en) 1992-08-19
GR3006306T3 (es) 1993-06-21
US5081028A (en) 1992-01-14
JP2713912B2 (ja) 1998-02-16
IE871967L (en) 1989-01-22
JP2619232B2 (ja) 1997-06-11
DE3781217D1 (de) 1992-09-24
DE3781217T2 (de) 1992-12-17
JPS6368097A (ja) 1988-03-26
PT85364B (pt) 1990-04-30
DK381287D0 (da) 1987-07-21
DK172259B1 (da) 1998-02-09
EP0254249A1 (en) 1988-01-27
IE60393B1 (en) 1994-07-13
DK381287A (da) 1988-01-23
PT85364A (en) 1987-08-01
AU602907B2 (en) 1990-11-01
JPH08242865A (ja) 1996-09-24
AU7594787A (en) 1988-02-18

Similar Documents

Publication Publication Date Title
ES2033747T3 (es) Preparacion de polipeptidos relacionados con factores de ligacion.
ES2130120T3 (es) Procedimiento para la preparacion de la adnasa humana.
PT80292B (pt) Preparacao de factor viii humano funcional
KR880009035A (ko) Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도
DK552684D0 (da) Desulfatohirudiner samt deres fremstilling og anvendelse
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
DK173883D0 (da) Substituerede 8-phenylxanthiner
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
DK467487D0 (da) Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis
NO167357C (no) Kosmetiske preparater for regenerering og hydratisering av hud samt fremgangsmaate for fremstilling av slike preparater.
DK215983A (da) Praeparater til hudpleje
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
AR227021A1 (es) Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
IT8021944A0 (it) Procedimento di preparazione e di isolamento dell'etere metilbutilico terziario.
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
NO159695C (no) Vannfri antitranspirasjons- og/eller deodorantkrem og fremstilling av denne.
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
NO167255C (no) Kosmetisk preparat for regenerering av hud og fremgangsmaate for fremstilling av preparatet
DK675389A (da) Terapeutiske praeparater til forebyggelse af fibrinaflejringer
IT1181883B (it) Composizioni cosmetiche comrendenti estratti lisati di hafnia e procedimento per la loro preparazione
DK273585D0 (da) Fremgangsmaade til fremstilling af medicinske kosmetiske praeparater
NO874200L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
IT1211463B (it) Composizione liquida per il trattamento preventivo e curativo di malattie crittogamiche di tipo oidio e procedimento per la messa in opera di tale composizione

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254249

Country of ref document: ES